Pharmacology

Cholinergic Drugs for NEET PG: Classification, Receptors and Organophosphate Poisoning

By Dr. Utsav Bhattacherjee, MBBS, MBA · 12 Oct 2026 · 19 min read

Last updated: 12 Oct 2026

On this page

Cholinergic drugs are tested in four predictable ways: classify the drug, match a receptor to its effect, pick the right agent for a clinical scenario, and manage organophosphate poisoning. This post is organized around those four tasks, so you can revise the whole topic in one sitting and know where each fact will be used.

What cholinergic drugs do

Cholinergic drugs are drugs that mimic or amplify the action of acetylcholine (ACh). Acetylcholine is the transmitter at every autonomic ganglion, at parasympathetic nerve endings on target organs, at the sympathetic fibers that supply sweat glands, at the adrenal medulla and at the neuromuscular junction. Drugs that raise acetylcholine levels, such as the anticholinesterases, therefore act in all of those places at once, while direct agonists act only where their receptor subtype sits.

There are two main ways to increase cholinergic activity. You can stimulate the receptors directly with an agonist, or you can inhibit acetylcholinesterase (AChE), the enzyme that destroys ACh, so that the transmitter your own nerves release lasts longer. That single split is the backbone of the classification.

Here is the clinical picture to hold in mind while reading. A farmer is brought to casualty after a pesticide spraying accident. He is sweating, salivating, has pinpoint pupils, a slow pulse and a wheezy chest. Every one of those signs is acetylcholine acting on a different receptor, and once you know the receptors, the signs stop being a list to memorize.

Cholinergic drugs classification

Cholinergic drugs are classified into direct-acting agonists, which bind the receptor themselves, and indirect-acting drugs, which are anticholinesterases. Direct agonists divide into choline esters and natural alkaloids. Anticholinesterases divide into reversible and irreversible inhibitors.

Group Subgroup Examples Identifier
Direct-acting Choline esters Acetylcholine, methacholine, carbachol, bethanechol Quaternary ammonium compounds that do not cross the blood-brain barrier
Direct-acting Natural alkaloids and synthetic agonists Pilocarpine, muscarine, arecoline, cevimeline Muscarinic agonists; pilocarpine is a tertiary amine
Indirect-acting Reversible anticholinesterases Physostigmine, neostigmine, pyridostigmine, edrophonium, rivastigmine, donepezil, galantamine Hold acetylcholinesterase temporarily
Indirect-acting Irreversible anticholinesterases Organophosphates such as parathion, malathion, echothiophate and the nerve agent sarin Phosphorylate the enzyme; the effect becomes permanent after aging

Nicotine deserves a mention even though its only therapeutic use is nicotine replacement for smoking cessation. It is the standard example of a nicotinic agonist, and it shows a biphasic action: stimulation of ganglia at low doses, then a depolarizing block at high doses.

Muscarinic and nicotinic receptors

Cholinergic drugs act through two receptor families. Muscarinic receptors are G-protein-coupled, and nicotinic receptors are ligand-gated ion channels. There are five muscarinic subtypes, M1 to M5, and one rule covers their signaling: the odd-numbered subtypes (M1, M3, M5) couple to Gq, and the even-numbered subtypes (M2, M4) couple to Gi.

Receptor Main location Signaling Effect of stimulation
M1 Autonomic and enteric ganglia, CNS, gastric secretory cells Gq (IP3 and DAG) Neuronal excitation; increased gastric acid secretion
M2 Heart: SA node, AV node, atria Gi (lower cAMP, K+ channel opening) Bradycardia and slower AV conduction
M3 Smooth muscle, exocrine glands, iris, ciliary muscle, vascular endothelium Gq (IP3 and DAG) Smooth muscle contraction, secretions, miosis, vasodilation through nitric oxide
Nm (muscle type) Neuromuscular junction Ligand-gated cation channel Skeletal muscle contraction
Nn (neuronal type) Autonomic ganglia and adrenal medulla Ligand-gated cation channel Ganglionic transmission and catecholamine release

M4 and M5 are mainly central and are rarely tested. Two points catch people out. Sweating is a cholinergic effect even though sweat glands belong to the sympathetic system. And most blood vessels have no parasympathetic nerve supply at all; they carry M3 receptors on the endothelium, so injected acetylcholine releases nitric oxide and lowers blood pressure.

The organ-by-organ effects of muscarinic stimulation are worth learning in a fixed order:

  • Eye: miosis from the sphincter pupillae, ciliary muscle contraction for near vision, and a fall in intraocular pressure as the drainage angle opens.
  • Heart: bradycardia, slower AV conduction and reduced atrial contractility.
  • Lungs: bronchoconstriction and increased bronchial secretions.
  • Gut: stronger peristalsis, more secretions and relaxed sphincters.
  • Bladder: detrusor contraction with relaxation of the trigone and sphincter, which causes micturition.
  • Glands: salivation, lacrimation and sweating.

Choline esters compared

The four choline esters differ in two ways that examiners like: which receptors they act on, and whether the cholinesterases destroy them. Acetylcholine itself is broken down within seconds, which is why it has almost no systemic use. The other three were developed to be more stable or more selective.

Drug Receptors Broken down by AChE Broken down by pseudocholinesterase Main use
Acetylcholine Muscarinic and nicotinic Yes Yes Intraocular miosis in cataract surgery; no systemic use
Methacholine Mainly muscarinic Yes, slowly No Bronchial provocation test for airway hyper-reactivity
Carbachol Muscarinic and nicotinic No No Topical or intraocular miosis
Bethanechol Muscarinic only No No Postoperative and neurogenic urinary retention, gut atony

Bethanechol is the one to remember for the bladder. It acts only on muscarinic receptors and resists both cholinesterases, so an oral dose gives a long, selective effect on the detrusor and the gut. It is the usual exam answer for postoperative or neurogenic urinary retention once mechanical obstruction has been excluded.

A quick way to hold the table: acetylcholine and carbachol hit both receptor families, methacholine and bethanechol are muscarinic only, and only acetylcholine is rapidly destroyed by both enzymes.

Pilocarpine and the other muscarinic alkaloids

Pilocarpine, obtained from the leaves of Pilocarpus jaborandi, is the natural alkaloid examiners ask about most. It is a tertiary amine that acts mainly on M3 receptors, and its signature effect is a burst of sweating and salivation. Its uses are narrow and specific:

  • Acute angle-closure glaucoma: pilocarpine causes miosis and pulls the iris away from the drainage angle. It is given after the pressure has been lowered with other drugs such as acetazolamide or mannitol, because an ischemic sphincter pupillae often does not respond at very high pressures.
  • Dry mouth: oral pilocarpine, or the related M3 agonist cevimeline, is used for xerostomia in Sjögren's syndrome and after head and neck radiotherapy.
  • Chronic open-angle glaucoma: pilocarpine was once standard, but prostaglandin analogues and beta-blockers have replaced it as first-line drugs.

Muscarine, found in mushrooms of the Inocybe and Clitocybe genera, produces a purely muscarinic picture, and atropine is the antidote. Arecoline, from the betel nut, is another muscarinic agonist, which contributes to the excess salivation seen in people who chew betel quid.

Anticholinesterases: how they work

Acetylcholinesterase sits in the synaptic cleft and splits acetylcholine into choline and acetate within milliseconds. An anticholinesterase blocks that step, so acetylcholine accumulates and every muscarinic and nicotinic effect appears together. What separates one drug from another is how long it holds the enzyme.

  • Reversible inhibitors bind temporarily. Carbamates such as neostigmine are slowly hydrolyzed off the enzyme over minutes to hours, while edrophonium binds by weak electrostatic forces and lets go within minutes.
  • Irreversible inhibitors are the organophosphates. They phosphorylate the esteratic site of the enzyme, and the effect lasts until the body synthesizes new enzyme.

A second distinction matters just as much: quaternary versus tertiary. Quaternary compounds such as neostigmine and pyridostigmine are charged, do not cross the blood-brain barrier and act peripherally. Tertiary compounds such as physostigmine, donepezil and rivastigmine are lipid soluble and act on the brain as well.

Drug Key feature Duration Main use
Edrophonium Non-carbamate; very short acting About 5 to 15 minutes Diagnostic testing in myasthenia gravis; separating myasthenic from cholinergic crisis
Neostigmine Quaternary carbamate; also stimulates the neuromuscular junction directly A few hours Reversal of non-depolarizing block, myasthenia gravis, postoperative ileus and urinary retention, acute colonic pseudo-obstruction
Pyridostigmine Quaternary carbamate; longer acting About 3 to 6 hours Maintenance treatment of myasthenia gravis
Physostigmine Tertiary carbamate; crosses the blood-brain barrier Short, roughly 30 minutes to 2 hours; repeat doses are often needed Anticholinergic poisoning, such as Datura or atropine toxicity
Donepezil, rivastigmine, galantamine Central anticholinesterases Hours; donepezil has a half-life of about 70 hours and is given once daily Mild to moderate Alzheimer's dementia

Neostigmine reverses a non-depolarizing block but does not reverse a depolarizing block from succinylcholine, and it can prolong it. Sugammadex is a newer reversal agent that binds rocuronium directly, but neostigmine remains the classical anticholinesterase answer.

Datura poisoning shows why tertiary versus quaternary matters. Ingestion of dhatura seeds produces hot dry skin, dilated pupils, delirium and urinary retention. Physostigmine can reverse both the central and the peripheral features, whereas neostigmine would correct only the peripheral ones.

Which cholinergic drug for which problem

Most clinical questions on this topic reduce to matching a drug to a scenario. Use this table as a self-test: cover the middle column and name the drug.

Clinical problem Drug usually chosen Why
Myasthenia gravis, long-term control Pyridostigmine Oral, acts for 3 to 6 hours, no central effects
Reversal of a non-depolarizing muscle relaxant Neostigmine with glycopyrrolate or atropine More acetylcholine at the junction; the antimuscarinic blunts bradycardia and secretions
Postoperative or neurogenic urinary retention without obstruction Bethanechol Selective muscarinic action on the detrusor, resistant to cholinesterases
Acute colonic pseudo-obstruction Neostigmine Boosts colonic motility once mechanical blockage is excluded
Acute angle-closure glaucoma Pilocarpine, after pressure-lowering drugs Miosis opens the drainage angle
Dry mouth in Sjögren's syndrome Pilocarpine or cevimeline M3 stimulation of the salivary glands
Anticholinergic poisoning (Datura, atropine) Physostigmine Crosses the blood-brain barrier
Alzheimer's dementia Donepezil, rivastigmine or galantamine Central anticholinesterase action
Bronchial provocation test Methacholine Provokes bronchospasm in hyper-reactive airways

Giving an antimuscarinic with neostigmine is deliberate. Neostigmine alone would cause bradycardia, drooling and bronchospasm along with its useful action at the muscle, so the paired drug removes the unwanted muscarinic effects.

Organophosphate poisoning

Organophosphate pesticide ingestion is among the commonest poisoning emergencies seen in Indian hospitals, which is a large part of why examiners keep returning to it. The compounds inhibit acetylcholinesterase irreversibly, so acetylcholine builds up at muscarinic receptors, at nicotinic receptors and in the brain at the same time.

System Features Memory aid
Muscarinic Diarrhea, urination, miosis, bradycardia, bronchorrhea and bronchospasm, emesis, lacrimation, salivation, sweating DUMBELS
Nicotinic Fasciculations, cramps, muscle weakness and paralysis including the respiratory muscles; tachycardia and hypertension from ganglionic stimulation Muscle plus ganglia
Central Anxiety, confusion, convulsions, coma and respiratory center depression Brain

A practical catch: nicotinic stimulation of the ganglia can cause tachycardia and dilated pupils, so a patient with organophosphate poisoning does not always show bradycardia and miosis. Do not rule the diagnosis out on those two signs alone. The vomitus or breath may smell of garlic or of the solvent in the pesticide, and a low plasma or red-cell cholinesterase level supports the diagnosis.

The treatment sequence is a favorite for stepwise questions:

  1. Airway, breathing and oxygen come first. Bronchorrhea and respiratory muscle weakness cause most early deaths.
  2. Remove contaminated clothing and wash the skin and hair so that absorption stops. Rescuers should wear gloves.
  3. Give atropine intravenously in repeated, escalating doses until the patient is atropinized. The most reliable endpoint is a clear chest, together with a heart rate above 80 per minute, a systolic pressure above 80 mmHg and dry axillae. Pupil size is a poor guide. Atropine treats muscarinic effects only; it does nothing for muscle weakness.
  4. Give pralidoxime to reactivate phosphorylated acetylcholinesterase. It is the only drug here that helps the nicotinic (muscle) effects, but it works only before the enzyme ages. Evidence for routine oxime use is mixed, yet the standard exam answer is atropine plus pralidoxime.
  5. Treat seizures with a benzodiazepine, and avoid succinylcholine, because plasma cholinesterase is also inhibited and paralysis is prolonged.

Aging explains why timing matters. After phosphorylation, the enzyme-inhibitor complex can lose an alkyl group, and the aged enzyme can no longer be reactivated by an oxime. Aging is very fast with nerve agents such as soman and slower with most pesticides, where dimethyl compounds age faster than diethyl ones.

Carbamate insecticides such as carbaryl and propoxur produce a similar picture, but the inhibition is reversible, so the illness is usually shorter and milder. Atropine is the mainstay, and pralidoxime is generally not needed.

Two late complications are tested by name:

  • Intermediate syndrome appears 24 to 96 hours after poisoning, once the acute cholinergic phase has settled. It causes weakness of the neck flexors and proximal limbs, cranial nerve palsies and respiratory muscle failure. It does not respond to atropine or pralidoxime and needs ventilatory support.
  • Organophosphate-induced delayed neuropathy appears one to three weeks later as a distal sensorimotor neuropathy, linked to inhibition of neuropathy target esterase. Tri-ortho-cresyl phosphate is the classic cause.

Myasthenic crisis versus cholinergic crisis

Consider a 28-year-old woman with myasthenia gravis who has taken pyridostigmine for a year. After a chest infection she becomes breathless and weak. If her pupils are small, her pulse is slow and she is drooling with loose stools, the muscarinic signs point to too much drug. If those signs are absent, the disease itself has worsened.

Feature Myasthenic crisis Cholinergic crisis
Cause Too little effective treatment; infection, surgery or stress Too much anticholinesterase
Muscle strength Weak Weak
Pupils Normal Small
Secretions Not increased; swallowing is weak Salivation, lacrimation and sweating increased
Bowel Normal Cramps and diarrhea
Fasciculations Absent Present
Heart rate Normal or fast Slow
Response to edrophonium Strength improves briefly Weakness worsens briefly
Management Ventilatory support, then immunotherapy such as IVIG or plasma exchange Ventilatory support, withhold anticholinesterases, atropine for muscarinic effects

In current practice the edrophonium test is rarely used, because it can precipitate collapse in the wrong patient. The airway comes first in both crises, and the muscarinic signs are what point to cholinergic excess.

Adverse effects and contraindications

Adverse effects are simply exaggerated muscarinic actions: salivation, sweating, abdominal cramps, diarrhea, bradycardia, bronchospasm, hypotension and blurred vision. Atropine reverses the muscarinic part of the toxicity, which is why an antimuscarinic is paired with neostigmine at reversal.

Cholinergic drugs are avoided in these settings:

  • Bronchial asthma and COPD, because of bronchoconstriction and increased secretions.
  • Peptic ulcer disease, because of increased acid secretion.
  • Mechanical intestinal or urinary obstruction, because stronger muscle contraction against a blocked outlet can make it worse.
  • Bradycardia, heart block and recent myocardial infarction.
  • Hyperthyroidism, where the risk of atrial fibrillation is higher.

High-yield points for last-minute revision

  • Odd-numbered muscarinic receptors (M1, M3, M5) signal through Gq; even-numbered ones (M2, M4) signal through Gi.
  • Acetylcholine and carbachol act on muscarinic and nicotinic receptors; methacholine and bethanechol are muscarinic only.
  • Bethanechol is for the bladder. Pilocarpine is for the drainage angle of the eye and for the dry mouth.
  • Neostigmine and pyridostigmine do not enter the brain; physostigmine does.
  • Edrophonium is the shortest-acting anticholinesterase, and pyridostigmine is the standard oral drug for myasthenia gravis.
  • In organophosphate poisoning, titrate atropine to a clear chest, not to the pupils, and give pralidoxime before aging.
  • Intermediate syndrome appears at one to four days and ignores atropine; delayed neuropathy appears at one to three weeks.
  • Avoid succinylcholine in organophosphate poisoning, because plasma cholinesterase is inhibited and paralysis is prolonged.
  • Pralidoxime is for organophosphates; it is generally not needed in confirmed carbamate poisoning.

How to revise cholinergic drugs for NEET PG

Autonomic pharmacology is one of the most dependable scoring areas in the subject. In our subject-wise weightage analysis, Pharmacology carries roughly 12 to 16 questions out of 180, about 7 to 9 percent of the paper, and the analysis lists autonomic drug mechanisms, including cholinergic drugs, among its most frequently tested areas.

A workable plan takes one evening. Redraw the receptor table from memory, then the drug-to-scenario table, and then attempt a block of questions without notes. Notice which rows you hesitated on and revise only those. For the wider method, see how to prepare Pharmacology for NEET PG and INI-CET, and use the Pharmacology practice questions to test recall under timed conditions.

Practise this on Reflex

Turn what you just read into recall with 14 years of tagged PYQs.

FAQ

Frequently asked questions

The questions aspirants ask most about this topic.

Cholinergic drugs are classified as direct-acting and indirect-acting. Direct-acting drugs are choline esters (acetylcholine, methacholine, carbachol, bethanechol) and natural alkaloids (pilocarpine, muscarine, arecoline). Indirect-acting drugs are anticholinesterases, which are either reversible (neostigmine, pyridostigmine, physostigmine, edrophonium) or irreversible (organophosphates).

Cholinergic drugs are drugs that mimic or enhance the action of acetylcholine. They do this either by stimulating muscarinic or nicotinic receptors directly, or by inhibiting acetylcholinesterase so that acetylcholine accumulates at the synapse. Drugs acting mainly on muscarinic receptors are also called parasympathomimetics.

Neostigmine is a quaternary compound that does not cross the blood-brain barrier, so it acts peripherally, including at the neuromuscular junction. It is used in myasthenia gravis and to reverse neuromuscular blockade. Physostigmine is a tertiary amine that enters the brain, so it is used to reverse central and peripheral anticholinergic poisoning, such as Datura or atropine toxicity.

Atropine is titrated until the chest is clear, meaning bronchial secretions and wheeze have stopped. Supporting endpoints are a heart rate above 80 per minute, a systolic blood pressure above 80 mmHg and dry axillae. Pupil size is not a reliable endpoint.

Pralidoxime is generally not needed in carbamate poisoning, because carbamate inhibition reverses on its own and the illness is usually brief. Its role is in organophosphate poisoning, where it reactivates the phosphorylated enzyme before aging makes the complex resistant.

Bethanechol is the standard answer for postoperative or neurogenic urinary retention without mechanical obstruction. It is a muscarinic-selective choline ester that resists cholinesterases and acts on the detrusor. Neostigmine is an alternative, and both are contraindicated when the outflow tract is obstructed.

About the author

Dr. Utsav Bhattacherjee, MBBS, MBA

CEO, ReflexPrep

LinkedIn

Stay ahead in your preparation

Get expert tips, exam updates, and high-yield insights delivered straight to your inbox.

No spam. Unsubscribe anytime.

More in Subject Notes

View all →